patent_id,patent_date,patent_title,patent_num_times_cited_by_us_patents,cpc_subclass_ids
12415802,2025-09-16,Dipyridine benzothiophene derivative compound,0,A61K|A61P|C07D
12297204,2025-05-13,"5-(substitutedphenyl)-7-thioxo-7,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as antibacterial agents",0,A61P|C07D|Y02A
12291514,2025-05-06,"Ethyl 2-[9-(2-hydroxypyridin-3-yl)-3,6-diphenyl-1,8-dioxo-3,4,9,10-tetrahydroacridine-10-yl]-acetate as an antimicrobial compound",0,A61P|C07D
12286436,2025-04-29,"Substituted pyrimido[4,5-b]indoles as CK2 inhibitors",0,A61P|C07D
12281087,2025-04-22,Ebselen analogues loaded nanoemulsion,0,A61K|C07D
12269827,2025-04-08,"Substituted pyrazino[1′,2′:1,5]pyrazolo[4,3-c][1,6]naphthyridines as CK2 inhibitors",0,A61K|A61P|C07D
12269826,2025-04-08,"7H-pyrido[4′,3′:4,5]pyrrolo[2,3-c][1,7]naphthyridine compounds as CK2 inhibitors",0,A61P|C07D
12264128,2025-04-01,Acid as an antioxidant compound,0,A61P|C07C
12264127,2025-04-01,"8-((3-formyl-4-hydroxyphenyl)diazenyl)naphthalene-1,3-disulfonic acid as an antioxidant compound",0,A61P|C07C
12258345,2025-03-25,"Pyrrolo[3,2-c]isoquinoline-2,3-dione compounds as CK2 inhibitors",0,A61P|C07D
12240851,2025-03-04,"Pyrido[3′,4′:4,5]pyrrolo[3,2-c]naphthyridine compounds as CK2 inhibitors",0,A61P|C07D
12227480,2025-02-18,1-(2-(substituted phenyl)-2-oxoethyl)-4-methylpyridin-1-ium bromide as anti-tubercular agents,0,A61K|A61P|C07D
12221450,2025-02-11,"5-(substitutedphenyl)-7-thioxo-7,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as antibacterial agents",0,A61P|C07D|Y02A
12221423,2025-02-11,"3-(3-fluorophenyl)-5-(4-methoxybenzylthio)-4-phenyl-4H-1,2,4-triazole as an antimicrobial compound",0,A61P|C07D|Y02A
12215107,2025-02-04,"Pyrazino[1′,2′:1,5]pyrazolo[4,3-c] [2,6] naphthyridine compounds as CK2 inhibitors",0,A61K|A61P|C07D
12215082,2025-02-04,(e)-1-(2-(4-substitutedphenyl)-2-oxoethyl)-4-((hydroxyimino)methyl)pyridinium bromides as antitubercular agents,0,A61P|C07D
12209089,2025-01-28,"Pyrimido[1′,6′: 1,5]pyrazolo[4,3-c] [2,7] naphthyridines as CK2 inhibitors",0,A61K|C07D
12208114,2025-01-28,Nano-sized chitosan/VS2 nanocomposite like flowers for antimicrobial applications,0,A61K|A61P|B82Y
12202846,2025-01-21,"FeAZD, NiAZD, and CuAZD complexes incorporating 1-(2-hydroxyphenylazo)-2-naphthol (H2AZD) for biological applications",0,A61P|C07B|C07F|Y02A
12202814,2025-01-21,"9-(6-flouro-2-hydroxypyridin-3-yl)-10-(2-hydroxyethyl)-3,6-diphenyl-3,4,6,7,9,10-hexahydroacridine1,8(2H,5H)-dione as an antimicrobial compound",0,A61P|C07D|Y02A
12202801,2025-01-21,4-cyano-1-(2-oxo-2-(substituted phenyl) ethyl) pyridin-1-ium bromides as anti-tubercular agents,0,A61P|C07D
12201650,2025-01-21,Method of making silver nanoparticles capped with Caralluma sinaica extract and treatment method using the same,0,A61K
12195430,2025-01-14,"6-(4,5-bis(4-bromophenyl)-2-(4-methoxyphenyl)-1H-imidazol-1-yl)hexanoic acid as an antimicrobial compound",0,A61P|C07D
12194029,2025-01-14,"Ethyl-1-(substitutedbenzoyl)-5-methylpyrrolo[1,2-a]quinoline-3-carboxylates as anticancer agents",0,A61K|A61P
12187733,2025-01-07,"5-(Substitutedphenyl)-7-Imino-7,8-Dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as anti-inflammatory agents",0,A61P|C07D
12187726,2025-01-07,"Imidazo[1,5-a]pyrido[4,3-e]pyrazines as CK2 inhibitors",0,A61K|A61P|C07D
12187718,2025-01-07,"1-cyclopropyl-6-fluoro-7-(4-((5-(4-methoxybenzylideneamino)-2-thioxo-1,3,4-thiadiazol-3(2H)-yl)methyl)piperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid as an anti-inflammatory and anticancer compound",0,A61P|C07D
12180245,2024-12-31,Separation and identification of myricetin-3-ogalactoside from casuarina glauca,0,A61K|C07H
12180235,2024-12-31,"Fabrication of novel nano-sized [4{3,4-bis-[(5-bromo-2-hydroxy-benzylidene)-amino]-phenyl }-phenyl-methanone] Ru(III) complex for pharmaceutical applications",0,A61K|A61P|C07F
12180218,2024-12-31,"Substituted pyrimido[4,5-b]indoles as CK2 inhibitors",0,A61P|C07D
12180209,2024-12-31,"Pyrrolo[3,2-c][2,6]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors",0,A61P|C07D
12180208,2024-12-31,"Pyrazolo[1,5-c]pyrido[3,4-e]pyrimidines as CK2 inhibitors",0,A61K|A61P|C07D
12180204,2024-12-31,"2-(benzo[d]thiazol-2-yl)-N′-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)acetimidamide as an antimicrobial compound",0,A61P|C07D
12180203,2024-12-31,"2-(benzo[d]thiazol-2-yl)-n′-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)acetimidamide as an antimicrobial compound",0,A61P|C07D
12180202,2024-12-31,"2-[(1,3-benzothiazol-2-yl)imino]-5,5-diphenylimidazolidin-4-one as an antimicrobial compound",0,A61P|C07D
12180201,2024-12-31,2-(benzo[d]oxazol-2-yl)-N′-(isonicotinoyloxy)acetimidamide as an antimicrobial compound,0,A61P|C07D
12180200,2024-12-31,2-(benzo[d]oxazol-2-yl)-n′-(isonicotinoyloxy)acetimidamide as an antimicrobial compound,0,A61P|C07D
12180199,2024-12-31,2-(benzo[d]oxazol-2-yl)-n′-(isonicotinoyloxy)acetimidamide as an antimicrobial compound,0,A61P|C07D
12180195,2024-12-31,"6-(6-bromo-2-oxo-2H-chromen-3-yl)-4-(2,4-dichlorophenyl)-2-alkoxynicotinonitrile as an antimicrobial compound",0,A61P|C07D
12180191,2024-12-31,"2-[(1H-benzimidazol-2-yl)imino]-5,5-diphenylimidazolidin-4-one as an antimicrobial compound",0,A61P|C07D
12180181,2024-12-31,"4-[4,5-bis(4-bromophenyl)-1-hexyl-1H-imidazol-2-yl]isoquinolin-3-ol as an antimicrobial compound",0,A61P|C07D|Y02A
12180180,2024-12-31,"4-[4,5-bis(4-bromophenyl)-1-hexyl-1H-imidazol-2-yl]isoquinolin-3-ol as an antimicrobial compound",0,A61P|C07D|Y02A
12180173,2024-12-31,"5-((2-isopropyl-5-methylphenoxy)methyl)-3-(naphthalen-1-yl)-1,2,4-oxadiazole as an anti-cancer and antimicrobial compound",0,A61P|C07D|Y02A
12180172,2024-12-31,"[3-(4-Methoxyphenyl)-1,2,4-oxadiazol-5-yl]methanol as an antitumor and antimicrobial compound",0,A61P|C07D|Y02A
12180170,2024-12-31,"2-(5-(3-fluorophenyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)acetic acid as an antimicrobial compound",0,A61P|C07D
12180169,2024-12-31,"4-[4,4-bis(4-bromophenyl)-5-oxo-2-thioxoimidazolidin-1-yl]butanoic acid as an antimicrobial compound",0,A61K|A61P|C07D|Y02A
12180168,2024-12-31,"3-[4,4-bis(4-nitrophenyl)-2,5-dioxoimidazolidin-1-yl]propanoic acid as an antimicrobial compound",0,A61K|A61P|C07D|Y02A
12180167,2024-12-31,"6-[4,4-bis(4-bromophenyl)-2,5-dioxoimidazolidin-1-yl]hexanoic acid as an antimicrobial compound",0,A61K|A61P|C07D|Y02A
12180166,2024-12-31,"6-(4,5-bis(4-bromophenyl)-2-(4-methoxyphenyl)-1H-imidazol-1-yl)hexanoic acid as an antimicrobial compound",0,A61P|C07D
12180162,2024-12-31,"2-amino-4-(4-bromophenyl)-6-methoxypyridine-3,5-dicarbonitrile as an antibacterial compound",0,A61K|A61P|C07D|Y02A
12180161,2024-12-31,"2-amino-4-(4-bromophenyl)-6-methoxypyridine-3,5-dicarbonitrile as an antibacterial compound",0,A61K|A61P|C07D|Y02A
12180143,2024-12-31,"8-((4-hydroxy-3-methoxyphenyl)diazenyl)naphthalene-1,3-disulfonic acid as an antioxidant compound",0,A61K|A61P|C07C
12178828,2024-12-31,Method for making nano-sized chitosan/VS2 nanocomposites,0,A61K|A61P|B82Y
12178802,2024-12-31,"3-(1-(3-(dimethylamino)propyl)-4,5-diphenyl-1H-imidazol-2-yl)pyridin-2-ol as an antitumor and antimicrobial compound",0,A61K|A61P|C07B|C07D|Y02A
12173005,2024-12-24,"Pyrimido[1′,6′:1,5]pyrazolo[4,3-b][1,7]naphthyridine compounds as CK2 inhibitors",0,A61P|C07D
12173003,2024-12-24,"Pyrrolo[3,2-C][2,6]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors",0,A61P|C07D
12173001,2024-12-24,"Pyrido[3,4-e][1,2,4]triazolo[4,3-c]pyrimidines as CK2 inhibitors",0,A61K|A61P|C07D
12172985,2024-12-24,6-(6-bromo-2-oxo-2H-chromen-3-yl)-4-(3-bromophenyl)-2-alkoxynicotinonitrile as antimicrobial compounds,0,A61P|C07D
12172973,2024-12-24,(E)-2-(3-Cyano-4-isobutoxyphenyl)-N′-(substituted benzylidene)-4-methylthiazole-5-carbohydrazides as anti-tubercular agents,0,A61P|C07D
12172972,2024-12-24,"3-(3-bromophenyl)-5-((2-isopropyl-5-methylphenoxy)methyl)-1,2,4-oxadiazole as an anti-cancer and antimicrobial compound",0,A61P|C07D
12172971,2024-12-24,N′-(2-naphthoyloxy)-2-(benzo[d]oxazol-2-yl)acetimidamide as an antimicrobial compound,0,A61P|C07B|C07D
12172970,2024-12-24,"2-(5-(3-fluorophenyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)acetic acid as an antimicrobial compound",0,A61P|C07D
12172968,2024-12-24,"4-[4,4-bis(4-chlorophenyl)-2,5-dioxoimidazolidin-1-yl]butanoic acid as an antimicrobial compound",0,A61K|A61P|C07D
12172967,2024-12-24,"3-(4,5-bis(4-bromophenyl)-2-(4-chlorophenyl)-1H-imidazol-1-yl)propanoic acid as an antimicrobial compound",0,A61P|C07D|Y02A
12172966,2024-12-24,2-(1H-imidazole-1-carbonyl)benzoic acid as an anticancer compound,0,A61P|C07B|C07D
12168662,2024-12-17,"Pyrido[4′,3′:4,5]pyrrolo[2,3-c][2,7]naphthyridines compounds as CK2 inhibitors",0,A61K|A61P|C07D
12168656,2024-12-17,"Process for making (e)-7-(4-((5-((2-chlorobenzylidene)amino)-2-thioxo-1,3,4-thiadiazol-3(2H)-yl)methyl)piperazin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid",0,A61P|C07D
12168651,2024-12-17,"9-(6-flouro-2-hydroxypyridin-3-yl)-10-(2-hydroxyethyl)-3,6-diphenyl-3,4,6,7,9,10-hexahydroacridine1,8(2H,5H)-dione as an antimicrobial compound",0,A61P|C07D|Y02A
12162875,2024-12-10,"1-cyclopropyl-6-fluoro-7-(4-((5(4-methoxybenzylideneamino-2-thioxo-1,3,4-thiadiazol-3(2H)-yl)methyl)piperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid as an anti-inflammatory and anticancer compound",0,A61P|C07D
12162845,2024-12-10,"3-(4-bromophenyl)-5-((2-isopropyl-5-methylphenoxy)methyl)-1,2,4-oxadiazole as an anti-cancer and antimicrobial compound",0,A61P|C07D
12162839,2024-12-10,"4,5-bis(4-bromophenyl)-2-(4-bromophenyl)-1-hexyl-1H-imidazole as an antimicrobial compound",0,A61P|C07D
12161660,2024-12-10,Nano-sized chitosan/VS2 nanocomposite like flowers for potential pharmaceutical applications,0,A61K|A61P|B82Y
12150922,2024-11-26,Methods of inhibiting cyclooxygenase (COX) using tolterodine,0,A61K
12145930,2024-11-19,4-thiazolidinone derivatives as EGFR inhibitors for anti-tumor activity,0,A61K|A61P|C07D
12145915,2024-11-19,(E)-2-(3-cyano-4-isobutoxyphenyl)-n′-(substituted benzylidene)-4-methylthiazole-5-carbohydrazides as anti-tubercular agents,0,A61P|C07D
12144821,2024-11-19,"Selective 3-prenyl 5-methyl ether, 7-o-rhamnoside flavone for the treatment of hepatic cancer",0,A61K|A61P
12144355,2024-11-19,Method for inhibiting fungal growth using Pyropia yezoensis,0,A01N|A01P|C12N
12134623,2024-11-05,"2,16-dioxapentacyclo[7.7.5.01,21.03,8.010,15]henicosa3(8),10,12,14-tetraene-7,20-dione as an antimicrobial compound",0,A61P|C07D|Y02A
12134622,2024-11-05,"2-benzo-[3,4-b]pyridine-[b,g]indeno[1,2;3,4]fluoreno-[1,2-d]oxonine-5,11,16,21-tetraone as an antimicrobial compound",0,A61P|C07D|Y02A
12134617,2024-11-05,"Pyrimido[1′6′:1,5]pyrazolo[4,3-c][1,7]naphthyridines as CK2 inhibitors",1,A61K|A61P|C07D
12134604,2024-11-05,"1-[4,5-bis(4-chlorophenyl)-1-hexyl-1H-imidazol-2-yl]-2-naphthol as an antimicrobial compound",0,A61P|C07D|Y02A
12129260,2024-10-29,"Benzofuro[3,2-c]chromen-6-one compounds as antibacterial agents",0,A61K|A61P|C07D|Y02A
12129259,2024-10-29,"Pyrazino[1′,2′:1,5]pyrazolo[4,3-b][1,6]naphthyridines compounds as CK2 inhibitors",0,A61K|A61P|C07D
12129257,2024-10-29,"Imidazo[1,2-a]pyrazine compounds as CK2 inhibitors",0,A61K|A61P|C07D
12129254,2024-10-29,"Pyrimido[6′,1′:2,3]imidazo[4,5-b][1,6]naphthyridine compounds as CK2 inhibitors",0,A61P|C07D
12129252,2024-10-29,"Pyrrolo[2,3-c][2,6]naphthyridine-8-carboxylic acids as CK2 inhibitors",0,A61P|C07D
12129241,2024-10-29,"9-(2-hydroxypyridin-3-yl)-10-(2-hydroxyethyl)-3,3,6,6-tetramethyl-3,4,6,7,9,10-hexahydroacridine1,8(2H,5H)-dione as an antimicrobial compound",0,A61P|C07D|Y02A
12128071,2024-10-29,Method of treating illness using lyophilized camel urine,0,A61K|Y02A
12128019,2024-10-29,Nanocomposite including abscisic acid-loaded collagen nanoparticles,0,A61K|A61P
12122775,2024-10-22,"Substituted pyrido[4,3-e]pyrrolo[1,2-a]pyrazines as CK2 inhibitors",0,A61K|A61P|C07D
12122770,2024-10-22,2-(benzo[d]oxazol-2-yl)-n'-(nicotinoyloxy)acetimidamide as an antimicrobial compound,0,A61P|C07B|C07D
12122752,2024-10-22,"5-(2,4,5-tris(4-chlorophenyl)-1H-imidazol-1-yl)pentanoic acid as an antimicrobial compound",0,A61P|C07D
12121561,2024-10-22,Composition for treating or preventing insulin resistance,0,A61K|C07K
12121555,2024-10-22,Method for inhibiting enzyme activity using Boscia senegalensis,0,A61K|C12N|C12Y
12121548,2024-10-22,Method for synthesizing a silver nanoparticle composition from Rhynchophorus ferrugineus larvae olivier,0,A61K|A61P
12115202,2024-10-15,Method of preventing cadmium-induced liver toxicity using a plant product derived from Achillea millefolium L,0,A61K|A61P
12115201,2024-10-15,Method for synthesizing silver nanoparticles from Amaranthus hybridus,0,A61K|A61P|B82Y
12103910,2024-10-01,Process for making selective organoselenium-based ligands,0,C07C|G01N|Y10T
12097233,2024-09-24,Composition for treating night blindness,0,A61K|A61P
12097232,2024-09-24,Method of preventing cadmium-induced renal toxicity using a plant product derived from Achillea millefolium L,0,A61K|A61P
12097228,2024-09-24,"Mixture of cyanobacteria, chitosan, and plant extracts for wound healing and eliminating pathogen bacteria",0,A61K|A61P
12092580,2024-09-17,Multivariate optimization of microwave digestion for determining of some elements in baobab (A. digitata L.) fruit pulp by ICP-MS,0,G01N|Y10T
12090143,2024-09-17,"4-chloro-N′-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)benzimidamide as an antimicrobial compound",0,A61K|A61P|C07D
12084478,2024-09-10,Fusion peptide inhibitors of human coronavirus 229E,0,A61P|C07K
12083220,2024-09-10,Combination treatment for antibiotic resistant infections,0,A61K|A61P|B82Y|Y02A
12083156,2024-09-10,Extracts derived from laser-irradiated rhizome of curcuma longa having enhanced antimicrobial activity,0,A61K|A61P
12083154,2024-09-10,Composition for treating bone loss,0,A61K|A61P
12083153,2024-09-10,Silver nanoparticle composition including biosynthesized silver nanoparticles and an extract of Farsetia aegyptiaca,0,A61K|A61P
12076354,2024-09-03,Antibiotic with spirulina platensis and plant extracts,0,A61K|A61P|C12N
12076339,2024-09-03,Method of making gold nanoparticles capped with Caralluma sinaica extract and treatment method using the same,0,A61K
12071437,2024-08-27,"Pyrazolo[1,5-a]pyrido[4,3-e]pyrimidine-2-carboxylic acids as CK2 inhibitors",0,A61K|A61P|C07D
12071407,2024-08-27,6-(4-hydroxyphenyl)-2-(2-ethoxyethoxy)-4-(4-methoxyphenyl)nicotinonitrile as an antimicrobial compound,0,A61P|C07D|Y02A
12065425,2024-08-20,"9-(2-hydroxyquinoline-3-YL)-10-[3-(dimethylamino)propyl]-3,4,6,7,9,10-hexahydroacridine-1,8(2H,5H)-dione as an antimicrobial compound",0,A61P|C07B|C07D|Y02A
12065424,2024-08-20,"6′(4-methoxyphenyl)-2′-alkoxy-3,4′-bipyridine-3′-carbonitrile as antimicrobial compounds",0,A61P|C07D|Y02A
12065411,2024-08-20,"Methyl 4-((5-(3-fluorophenyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)methyl)benzoate as an antimicrobial compound",0,A61P|C07D
12060359,2024-08-13,Selective hypoxia inducible factor prolyl-hydroxylase inhibitors,0,A61K|C07D
12060335,2024-08-13,"2-(benzo[d]oxazol-2-yl)-N′-(3,5-dichlorobenzoyloxy)acetimidamide as an antimicrobial compound",0,A61P|C07B|C07D
12060329,2024-08-13,"6′-(2-bromophenyl)-2′-ethoxy-3,4′-bipyridine-3′-carbonitrile as an antioxidant compound",0,A61P|C07D
12059405,2024-08-13,"3-(2,4,5-tris(4-chlorophenyl)-1H-imidazol-1-yl) propanoic acid as an antimicrobial compound",0,A61K|A61P|C07D
12054473,2024-08-06,"6′(4-methoxyphenyl)-2′-alkoxy-3,4′-bipyridine-3′- carbonitrile as antimicrobial compounds",0,A61P|C07D|Y02A
12054464,2024-08-06,"Methyl 4-((5-(3-fluorophenyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)methyl)benzoate as an antimicrobial compound",0,A61P|C07D
12054460,2024-08-06,"9-(5-bromo-2-hydroxyphenyl)-10-[3-(dimethylamino)propyl]-3,4,6,7,9,10-hexahydroacridine-1,8(2H,5H)-dione as an antimicrobial compound",0,A61P|C07D
12054451,2024-08-06,Water soluble platinum (II) amino acid schiff base as an antitumor drug,0,A61P|C07C|C07F
12053499,2024-08-06,Sustainable nanocomposition for treatment of osteoporosis,0,A61K
12053497,2024-08-06,Method for synthesizing silver nanoparticles from Amaranthus hybridus,0,A61K|A61P|B82Y
12049459,2024-07-30,"3-(4,5-Diphenyl-2-(pyridin-3-yl)-1H-imidazol-1-yl)-N,N-dimethylpropan-1-amine as an anticancer compound",0,A61K|A61P|C07D
12049454,2024-07-30,"5-((2-isopropyl-5-methylphenoxy)methyl)-3-(naphthalen-1-yl)-1,2,4-oxadiazole as an anti-cancer and antimicrobial compound",0,A61P|C07D|Y02A
12043609,2024-07-23,"6′(4-methoxyphenyl)-2′-alkoxy-3,4′-bipyridine-3′-carbonitrile as antimicrobial compounds",0,A61P|C07D|Y02A
12043608,2024-07-23,"2-(Benzo[b]thiophen-3-yl)-1-butyl-4,5-diphenyl-1H-imidazole as an anti-inflammatory and anti-microbial compound",0,A61P|C07D
12037626,2024-07-16,Jute filters to reduce ammonia inhibition effects of chicken manure for biogas production,0,B01D|C02F|C12M|C12N|C12P|Y02E
12037331,2024-07-16,"1-Cyclopropyl-6-fluoro-7-4((5-(4-methoxybenzylideneamino)-2-thioxo-1,3,4-thiadiazol-3(2h)-yl)methyl)piperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid as an anti-inflammatory and anticancer compound",0,A61P|C07D
12024518,2024-07-02,"Pyrazolo[4,3-C][1,6]naphthyridines as CK2 inhibitors",0,A61P|C07D
12018028,2024-06-25,"5-substituted aminopyrazino[2′,1′:2,3]imidazo[4,5-c][2,7]naphthyridine compounds as CK2 inhibitors",0,A61P|C07D
12018026,2024-06-25,"Pyrido[4,3-e][1,2,3]triazolo[1,5-a]pyrimidine as CK2 inhibitors",0,A61K|A61P|C07D
12017999,2024-06-25,"1-[4,5-bis(4-chlorophenyl)-1-hexyl-1H-imidazol-2-yl]-2-naphthol as an antimicrobial compound",0,A61P|C07D|Y02A
12017998,2024-06-25,"5-(2,4,5-tris(4-chlorophenyl)-1H-imidazol-1-yl)pentanoic acid as an antimicrobial compound",0,A61P|C07D
12012414,2024-06-18,"Imidazo[1,5-a]pyrido[4,3-e]pyrimidines as CK2 inhibitors",0,A61K|A61P|C07D
12012407,2024-06-18,"Pyrazolo[1,5-a]pyrido[4,3-e]pyrimidine-3-carboxylic acids as CK2 inhibitors",0,A61K|A61P|C07D
12012406,2024-06-18,"Pyrido[4,3-e]pyrrolo[1,2-a]pyrimidine as CK2 inhibitors",0,A61P|C07D
12012391,2024-06-18,"9-(2-hydroxyquinoline-3-yl)-10-[3-(dimethylamino)propyl]-3,4,6,7,9,10-hexahydroacridine-1,8(2H,5H)-dione as an antimicrobial compound",0,A61P|C07B|C07D|Y02A
12012388,2024-06-18,"4-chloro-n'-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)benzimidamide as an antimicrobial compound",0,A61P|C07B|C07D
12012385,2024-06-18,"4,5-bis(4-methoxyphenyl)-1-hexyl-2-phenyl-1H-imidazole as an antimicrobial compound",0,A61P|C07D|Y02A
12011473,2024-06-18,Green nanoparticle composition for treatment of histoplasmosis,0,A61K|A61P
12006317,2024-06-11,"5-substituted aminopyrimido [6′,1′:2,3] imidazo [4,5-c] [2,6] naphthyridine compounds as CK2 inhibitors",0,A61P|C07D
12006313,2024-06-11,"7-(4-((5-(benzylideneamino)-2-thioxo-1,3,4-thiadiazol-3(2H)-yl)methyl)piperazin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid as an anti-inflammatory and anticancer compound",0,A61P|C07D
12006296,2024-06-11,5-(4-methoxyphenyl)-1-hexyl-2-(4-nitrophenyl)-4-phenyl-1H-imidazoleas an antimicrobial compound,0,A61P|C07D
12006295,2024-06-11,"4,5-bis(4-bromophenyl)-2-(4-bromophenyl)-1-hexyl-1H-imidazole as an antimicrobial compound",0,A61P|C07D
12006293,2024-06-11,Bis diselenide-based schiff bases as deubiquitination signaling pathway modulators,6,A61K|C07D
12006288,2024-06-11,"3-(4-chlorophenyl)-5-{[5-methyl-2-(propan-2-yl)phenoxy]methyl}-1,2,4-oxadiazole as an antitumor and antimicrobial compound",0,A61P|C07D
12006278,2024-06-11,"4,4′-naphthalene-1,5-diylbis(diazene-2,1-diyl)diphenol as an antioxidant compound",0,A61P|C07C
11999755,2024-06-04,Effective anticancer drug candidate of dinuclear palladium (II) bis-dihydrozone malonyl complex,0,A61K|A61P|C07F
11999736,2024-06-04,"Pyrazino[2′,1′:2,3]imidazo[4,5-b][1,7]naphthyridines compounds as CK2 inhibitors",2,A61P|C07D
11999735,2024-06-04,"5-substituted aminopyrimido [6′,1′:2,3] imidazo [4,5-c] [2,6] naphthyridine compounds as CK2 inhibitors",0,A61P|C07D
11999714,2024-06-04,"3-(4,5-Diphenyl-2-(pyridin-3-yl)-1H-imidazol-1-yl)-N,N-dimethylpropan-1-amine as an antimicrobial compound",0,A61P|C07D
11999712,2024-06-04,"2-(benzo[b]thiophen-3-yl)-1-butyl-4,5-diphenyl-1H-imidazole as an anti-inflammatory and anti-microbial compound",0,A61P|C07D
11999711,2024-06-04,"2-(benzo[b]thiophen-3-yl)-1-butyl-4,5-diphenyl-1H-imidazole as an anti-inflammatory and anti-microbial compound",0,A61P|C07D
11999708,2024-06-04,Thiazole tethered organoselenides as 5-lipoxygenase inhibitors,0,A61K|C07D
11999707,2024-06-04,"N′-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)-1-naphthimidamide as an antimicrobial compound",0,A61P|C07D
11999706,2024-06-04,"4-chloro-N′-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)benzimidamide as an antimicrobial compound",0,A61P|C07B|C07D
11999705,2024-06-04,"4-chloro-N′-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)benzimidamide as an antimicrobial compound",0,A61P|C07B|C07D
11999704,2024-06-04,"1-(2-hydroxybenzylideneamino)-5-phenylimidazolidine-2,4-dione as an antimicrobial compound",0,A61P|C07D|Y02A
11999703,2024-06-04,"5-(2,4,5-tris(4-chlorophenyl)-1H-imidazol-1-yl)pentanoic acid as an antimicrobial compound",0,A61P|C07D
11999702,2024-06-04,"4,5-bis(4-chlorophenyl)-1-hexyl-2-(3,4-dimethoxyphenyl)-1H-imidazole as an antimicrobial compound",0,A61P|C07D
11999701,2024-06-04,"4,5-bis(4-chlorophenyl)-2-phenyl-1H-imidazol-1-yl as an antimicrobial compound",0,A61K|A61P|C07D
11999700,2024-06-04,"[4,4-bis(4-nitrophenyl)-2,5-dioxoimidazolidin-1-yl]acetic acid as an antimicrobial compound",0,A61K|A61P|C07D
11999685,2024-06-04,Dispersive liquid-liquid microextraction of copper and zinc ions from real samples using selective organoselenium-based ligands,0,C07C|G01N|Y10T
11998582,2024-06-04,Composition for treating bone loss,0,A61K|A61P
11998566,2024-06-04,Method of synthesizing a silver nanoparticle composition using an extract of Salsola tetrandra,0,A61K|A61P
11998532,2024-06-04,"Substituted 1,3,4-oxadiazole derivatives as anti-tubercular agents",0,A61K|A61P
11998515,2024-06-04,Enhancement of curcumin plasma levels using eucalyptol co-administration,0,A61K
11993579,2024-05-28,"3-(1-(3-(dimethylamino)propyl)-4,5-diphenyl-1h-imidazol-2-yl)pyridin-4-ol as an anti-microbial compound",0,A61P|C07D
11993575,2024-05-28,"Ethyl [4,4-bis(4-bromophenyl)-2,5-dioxoimidazolidin-1-yl]acetate as an antimicrobial compound",0,A61K|A61P|C07D
11987581,2024-05-21,"Imidazo[1,2-c]pyrido[3,4-e]pyrimidine-2-carboxylic acids as CK2 inhibitors",1,A61P|C07D
11987578,2024-05-21,"7-(4-((5-(2-chlorobenzylideneamino)-2-thioxo-1,3,4-thiadiazol-3(2H)-yl)methyl)piperazin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid as an anti-inflammatory compound",0,A61P|C07D
11987571,2024-05-21,"Ethyl 2-[9-(6-chloro-2-hydroxyquinolin-3-yl)-3,6-diphenyl-1,8-dioxo-3,4,9,10-tetrahydroacridine-10-yl]-acetate as an antimicrobial compound",0,A61P|C07D|Y02A
11987570,2024-05-21,"10-(2-hydroxyethyl)-9-(2-hydroxypyridin-3-yl)-3,4,6,7,9,10-hexahydroacridine-1,8(2H,5H)-dione as an antimicrobial compound",0,A61K|A61P|C07D
11987563,2024-05-21,"3-cyano 4,5-diphenyl furan-2-carboxamides as antitubercular agents",0,A61K|A61P|C07D
11987559,2024-05-21,"1-(4-bromobenzylideneamino)-5-phenylimidazolidine-2,4-dione as an antimicrobial compound",0,A61K|A61P|C07D|Y02A
11987543,2024-05-21,"8-(4-bromobenzylideneamino)naphthalene-1,3-disulfonic acid as an antioxidant compound",0,A61P|C07C
11986476,2024-05-21,"(6-methyl-4-substitutedphenyl-2-oxo/thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)(piperidin-1-yl)methanones as antitubercular agents",0,A61K|A61P
11986465,2024-05-21,"2-amino-4-(4-bromophenyl)-6-ethoxypyridine-3,5-dicarbonitrile as an antibacterial compound",1,A61K|A61P|Y02A
11986461,2024-05-21,"3-(1-(3-(dimethylamino)propyl)-4,5-diphenyl-1H-imidazol-2-yl)pyridin-2-ol as an antitumor and antimicrobial compound",0,A61K|A61P|C07B|C07D|Y02A
11981949,2024-05-14,Jute filters to reduce ammonia inhibition effects of chicken manure for biogas production,0,B01D|C02F|C12M|C12N|C12P|Y02E
11981676,2024-05-14,"Pyrazolo[4,3-c][2,6]naphthyridines as CK2 inhibitors",1,A61K|A61P|C07D
11981675,2024-05-14,"Pyrrolo[3,2-C]quinoline-2,3-dione compounds as CK2 inhibitors",0,A61P|C07D
11981655,2024-05-14,"3-(4,5-diphenyl-2-(pyridin-3-yl)-1H-imidazol-1-yl)-N,N-dimethylpropan-1-amine as an anticancer compound",0,A61K|A61P|C07D
11981654,2024-05-14,"4-[4,5-bis(4-bromophenyl)-1-hexyl-1H-imidazol-2-yl]isoquinolin-3-ol as an antimicrobial compound",0,A61P|C07D|Y02A
11981647,2024-05-14,"3-(4-methoxyphenyl)-5-{[5-methyl-2-(propan-2-yl)phenoxy]methyl}-1,2,4-oxadiazole as an antitumor and antimicrobial compound",0,A61P|C07B|C07D
11981646,2024-05-14,"3-(4-methoxyphenyl)-5-{[5-methyl-2-(propan-2-yl)phenoxy]methyl}-1,2,4-oxadiazole as an antitumor and antimicrobial compound",0,A61P|C07B|C07D
11981645,2024-05-14,N′-(2-naphthoyloxy)-2-(benzo[d]oxazol-2-yl)acetimidamide as antimicrobial compound,1,A61P|C07D|Y02A
11981643,2024-05-14,Oxoimidazolidine derivatives as anti-tubercular agents,0,A61P|C07D
11981642,2024-05-14,"4-(4,5-bis(4-bromophenyl)-2-(4-chlorophenyl)-1H-imidazol-1-yl)butanoic acid as an antimicrobial compound",0,A61P|C07D
11981641,2024-05-14,"4,5-bis(4-bromophenyl)-1-hexyl-2-(3,4-dimethoxyphenyl)-1H-imidazole as an antimicrobial compound",0,A61P|C07D|Y02A
11981640,2024-05-14,"4,5-bis(4-chlorophenyl)-1-hexyl-2-(3-hydroxy-4-methoxyphenyl)-1H-imidazole as an antimicrobial compound",0,A61P|C07D|Y02A
11981627,2024-05-14,Dispersive liquid-liquid microextraction of copper and zinc ions from real samples using selective organoselenium-based ligands,0,C07C|G01N|Y10T
11976080,2024-05-07,"Benzofuro[3,2-c]chromen-6-one compounds as antibacterial agents",0,A61K|A61P|C07D|Y02A
11976079,2024-05-07,"Pyrazino[1′,2′:1,5]pyrazolo[4,3-b][1,6]naphthyridines compounds as CK2 inhibitors",1,A61K|A61P|C07D
11976076,2024-05-07,"Substituted 7,8-dihydropyrimido[4,5-d]pyrimidines as anti-tubercular agents",0,A61P|C07D
11976070,2024-05-07,"Substituted pyrimido[6â€™, 1â€™:2,3]imidazo[4,5-c][1,6]naphthyridines as CK2 inhibitors",0,A61P|C07D
11976066,2024-05-07,Substituted 7-amino-3-(substituted benzoyl)indolizine-1-carboxylates as anti-tubercular agents,0,A61P|C07D
11976055,2024-05-07,"2-(1-(3-(dimethylamino)propyl)-4,5-diphenyl-1H-imidazol-2-yl)pyridin-3-ol as an antitumor and antimicrobial compound",0,A61K|A61P|C07B|C07D
11976051,2024-05-07,"N′-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)-2-naphthimidamide as an antimicrobial compound",0,A61P|C07D|Y02A
11976050,2024-05-07,"N′-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)-1-naphthimidamide as an antimicrobial compound",0,A61P|C07D
11976048,2024-05-07,"1-(2-hydroxybenzylideneamino)-5-phenylimidazolidine-2,4-dione as an antimicrobial compound",0,A61P|C07D|Y02A
11976047,2024-05-07,"4,5-bis(4-bromo-phenyl)-1-hexyl-2-(2- methoxyphenyl)-1H-imidazole as an antimicrobial compound",0,A61P|C07D|Y02A
11976046,2024-05-07,"4-(4,5-bis(4-bromophenyl)-2-(4-methoxyphenyl)-1H-imidazol-1-yl)benzoic acid as an antimicrobial compound",0,A61P|C07D|Y02A
11976045,2024-05-07,"3-(4,5-bis(4-bromophenyl)-2-(4-chlorophenyl)-1H-imidazol-1-yl)propanoic acid as an antimicrobial compound",0,A61P|C07D|Y02A
11976043,2024-05-07,"3-cyano-2-ethoxy-9-(2-nitrobenzylidene)-4-(2-nitrophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridine as an antimicrobial compound",0,A61P|C07D
11976042,2024-05-07,"9-(5-bromo-2-hydroxyphenyl)-10-[3-(dimethylamino)propyl]-3,4,6,7,9,10-hexahydroacridine-1,8(2H,5H)-dione as an antimicrobial compound",0,A61P|C07D
11976041,2024-05-07,"9-(5-bromo-2-hydroxyphenyl)-10-[3-(dimethylamino)propyl]-3,4,6,7,9,10-hexahydroacridine-1,8(2H,5H)-dione as an antimicrobial compound",0,A61P|C07D
11976033,2024-05-07,Selective organoselenium-based ligands for the dispersive liquid-liquid microextraction of copper and zinc ions from real samples,1,C07C|G01N|Y10T
11976031,2024-05-07,"8-((4-hydroxy-3-methylphenyl)diazenyl)naphthalene-1,3-disulfonic acid as an antioxidant compound",0,A61P|C07C
11975038,2024-05-07,Therapeutic composition including phenolic compounds derived from opuntia littoralis,0,A61K
11974995,2024-05-07,"6′-(4-bromophenyl)-2′-methoxy-3,4′-bipyridine-3′-carbonitrile as an antioxidant compound",0,A61K
11974991,2024-05-07,"Adenosine receptor activity of methyl/ethyl 3-(substituted benzoyl)-6,8-dimethylindolizine-2-substituted-1-carboxylates",0,A61K
11970741,2024-04-30,Genetic sex-determination method,0,C12Q
11970509,2024-04-30,Water soluble nano-sized imine Ru(III) complex based on 4-aminobenzene sodium sulphonate for biomedical applications,0,A61K|A61P|C07F|Y02A
11970505,2024-04-30,"Pyridino-2,16-dioxapentacyclo[7.7.5.01,21.03,8.010,15]henicosa3(8),10,12,14-tetraene-7,20-dione as an antimicrobial compound",0,A61P|C07D|Y02A
11970504,2024-04-30,"2-benzo-[3,4-b] quinolino-{b,g]indeno [1′,2′:3,4] fluoreno-[1,2-d] Oxonine-5,11,16,21-tetraone as an antimicrobial compound",0,A61K|A61P|C07D|Y02A
11970499,2024-04-30,"Pyrazolo[1,5-c]pyrimidine compounds as CK2 inhibitors",0,A61K|A61P|C07D
11970496,2024-04-30,"Pyrrolo[3,2-c]quinoline compounds as CK2 inhibitors",0,A61K|A61P|C07D
11970488,2024-04-30,"2-(benzo[d]thiazol-2-yl)-N'-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)acetimidamide as an antimicrobial compound",0,A61P|C07D
11970487,2024-04-30,"7-(4-((5-(benzylideneamino)-2-thioxo-1,3,4-thiadiazol-3(2h)-yl)methyl)piperazin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid as an anti-inflammatory and anticancer compound",0,A61P|C07D
11970478,2024-04-30,"9-(2-hydroxyquinolin-3-yl)-10-(2-hydroxyethyl)-3,3,6,6-tetramethyl-3,4,6,7,9,10-hexahydroacridine1,8(2H,5H)-dione as an antimicrobial compound",0,A61P|C07D|Y02A
11970477,2024-04-30,"9-(2-hydroxyquinoline-3-yl)-10-[3-(dimethylamino)propyl]-3,4,6,7,9,10-hexahydroacridine-1,8(2H,5H)-dione as an antimicrobial compound",0,A61P|C07D|Y02A
11970476,2024-04-30,"6′-(4-chlorophenyl)-2′-alkoxy-3,4′-bipyridine-3′-carbonitriles as antimicrobial compounds",0,A61P|C07D|Y02A
11970475,2024-04-30,"4-(1-(2-Hydroxypropyl)-4,5-diphenyl-1H-imidazol-2-yl)pyridin-3-ol as an antimicrobial compound",0,A61P|C07B|C07D|Y02A
11970472,2024-04-30,"5-((2-isopropyl-5-methylphenoxy)methyl)-3-(naphthalen-1-yl)-1,2,4-oxadiazole as an anti-cancer and antimicrobial compound",0,A61P|C07D|Y02A
11970471,2024-04-30,"3-(4-chlorophenyl)-5-{[5-methyl-2-(propan-2-yl)phenoxy]methyl }- 1,2,4-oxadiazole as an antitumor and antimicrobial compound",0,A61P|C07D
11970468,2024-04-30,"2-(benzo[d]oxazol-2-yl)-N′-(3,5-dichlorobenzoyloxy)acetimidamide as an antimicrobial compound",2,A61P|C07B|C07D
11970467,2024-04-30,N′-(2-naphthoyloxy)-2-(benzo[d]oxazol-2-yl)acetimidamide as an antimicrobial compound,2,A61P|C07B|C07D
11970466,2024-04-30,"4-((5-(3-fluorophenyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)methyl)benzoic acid as an antimicrobial compound",0,A61P|C07D|Y02A
11970465,2024-04-30,"Ethyl {[4-benzoyl-5-(3-fluorophenyl)-4H-1,2,4-triazol-3-yl]thio}acetate as an antimicrobial compound",0,A61P|C07D|Y02A
11970462,2024-04-30,"Ethyl 3-[4,4-bis(4-chlorophenyl)-2,5-dioxoimidazolidin-1-yl]propanoate as an antimicrobial compound",0,A61K|A61P|C07D|Y02A
11970461,2024-04-30,"1-hexyl-5-(4-methoxyphenyl)-2,4-diphenyl-1H-imidazole as an antimicrobial compound",0,A61P|C07D|Y02A
11970460,2024-04-30,"4-(4,5-bis(4-bromophenyl)-2-phenyl-1H-imidazol-1-yl)benzoic acid as an antimicrobial compound",0,A61P|C07B|C07D|Y02A
11970459,2024-04-30,"3-(4,5-bis(4-bromophenyl)-2-(4-chlorophenyl)-1H-imidazol-1-yl)propanoic acid as an antimicrobial compound",0,A61P|C07D|Y02A
11970458,2024-04-30,"4,5-bis(4-bromophenyl)-1-hexyl-2-(4-nitrophenyl)-1H-imidazole as an antimicrobial compound",0,A61P|C07D
11970455,2024-04-30,"7-(4-fluorobenzylidene)-4-(4-fluorophenyl)-2-methoxy-6,7-dihydro-5H-cyclopenta[b]pyridine-3-carbonitrile as an antimicrobial compound",0,A61P|C07D|Y02A
11970454,2024-04-30,"Ethyl-2[9-2(2-hydroxyquinolin-3-yl)-1,8-dioxo-3,4,9,10-tetrahydroacridine-10-yl]-acetate as an antimicrobial compound",0,A61P|C07B|C07D|Y02A
11970453,2024-04-30,"2-ethoxy-8-(4-fluorobenzylidene)-4-(4-fluorophenyl)-5,6,7,8-tetrahydroquinoline-3-carbonitrile as an antimicrobial compound",0,A61P|C07D
11970451,2024-04-30,6-(3-hydroxyphenyl)-2-methoxy-4-(3-methylphenyl)nicotinonitrile as an antimicrobial compound,0,A61P|C07D
11970440,2024-04-30,"8-(3-chlorobenzylideneamino)naphthalene-1,3-disulfonic acid as an antioxidant compound",0,A61P|C07C
11970439,2024-04-30,"8-(4-chlorobenzylideneamino)naphthalene-1,3-disulfonic acid as an antioxidant compound",0,A61P|C07C
11970437,2024-04-30,"8-((4-hydroxynaphthalen-1-yl)diazenyl)naphthalene-1,3-disulfonic acid as an antioxidant compound",0,A61K|C07C
11969442,2024-04-30,Covid-19 binding aerosols,1,A01N|A01P|A61K
11964982,2024-04-23,"5-(3-substituted phenyl)-pyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,8H)-trione derivatives as anticancer agents",0,A61P|C07D
11964981,2024-04-23,"Substituted pyrimido[4,5-b]indoles as CK2 inhibitors",0,A61P|C07D
11964976,2024-04-23,"Substituted pyrido[3′,4′:4,5]pyrrolo[3,2-c][1,6]naphthyridines as CK2 inhibitors",1,A61P|C07D
11964975,2024-04-23,"5-substituted aminopyrimido[6′,1′:2,3]imidazo[4,5-c][2,6]naphthyridine compounds as CK2 inhibitors",1,A61P|C07D
11964974,2024-04-23,"Imidazo[1,2-c]pyrido[3,4-e]pyrimidine-3-carboxylic acids as CK2 inhibitors",2,A61P|C07D
11964970,2024-04-23,"7-(4-((5-(3-bromobenzylideneamino)-2-thioxo-1,3,4-thiadiazol-3(2H)-yl)methyl)piperazin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid as an anti-inflammatory and anticancer compound",0,A61P|C07D
11964959,2024-04-23,"3-(4,5-Diphenyl-2-(pyridin-3-yl)-1H-imidazol-1-yl)-N,N-dimethylpopan-1-amine as an antimicrobial compound",0,A61P|C07D
11964954,2024-04-23,"N'-[(2-chlorobenzoyl)oxy]-1,3-benzothiazole-2-carboximidamide as an antitumor and antimicrobial compound",0,A61P|C07D
11964946,2024-04-23,"4,5-bis(4-methoxyphenyl)-1-hexyl-2-(4-nitrophenyl)-1H-imidazole as an antimicrobial compound",0,A61P|C07D|Y02A
11963948,2024-04-23,"2-(4-chlorophenyl)-4,5-bis(4-chlorophenyl)-1H-imidazole as an antimicrobial compound",0,A61K|A61P
11958857,2024-04-16,"5-(1H-indol-3-yl)-1,3-substitutedpyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,8H)-trione as anticancer agents",0,A61P|C07D
11958853,2024-04-16,"6-substituted aminopyrazino[2′,1′:2,3]imidazo[4,5-c][1,7]naphthyridine compounds as CK2 inhibitors",0,A61P|C07D
11958851,2024-04-16,"Pyrrolo[3,2-c]quinoline compounds as CK2 inhibitors",0,A61K|A61P|C07D
11958848,2024-04-16,"7-(4-((5-(2-chlorobenzylideneamino)-2-thioxo-1,3,4-thiadiazol-3(2H)-yl)methyl)piperazin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid as an anti-inflammatory compound",0,A61P|C07D
11958847,2024-04-16,Pyrazolidinedione derivatives and their use as PPAR-gamma inhibitors,0,A61P|C07D
11958843,2024-04-16,"2-(benzo[d]oxazol-2-yl)-n′-(2-(5-phenyl-1,3,4-oxadiazol-2- ylthio)acetoxy)acetimidamide as an antimicrobial compound",0,A61P|C07B|C07D
11958835,2024-04-16,6-(6-bromo-2-oxo-2H-chromen-3-yl)-4-(4-chlorophenyl)-2-alkoxynicotinonitrile as antimicrobial agents,1,A61P|C07D|Y02A
11958832,2024-04-16,"2-alkoxy[4,3:6,3-terpyridine]-3-carbonitriles as antimicrobial compounds",0,A61P|C07D
11958829,2024-04-16,"3-(4,5-diphenyl-2-(pyridin-3-YL)-1H-imidazol-1-YL)-N,N-dimethylpopan-1-amine as an antimicrobial compound",1,A61P|C07D
11958828,2024-04-16,"4,5-bis(4-bromophenyl)-1-hexyl-2-(3-pyridyl)-1H-imidazole as an antimicrobial compound",0,A61P|C07D|Y02A
11958827,2024-04-16,"9-(2-hydroxyquinoline-3-yl)-10-[3-(dimethylamino)propyl]-3,4,6,7,9,10-hexahydroacridine-1,8(2H,5H)-dione as an antimicrobial compound",0,A61P|C07B|C07D|Y02A
11958826,2024-04-16,"6′-(2-chlorophenyl)-2′-ethoxy-3,4′-bipyridine-3′- carbonitrile as an antimicrobial compound",0,A61P|C07D|Y02A
11958817,2024-04-16,"4-chloro-n′-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)benzimidamide as an antimicrobial compound",0,A61K|A61P|C07D
11958816,2024-04-16,"N′-({[(5-phenyl-1,3,4-oxadiazol-2-yl)sulfanyl]acetyl}oxy)benzenecarboximidamide as an antimicrobial compound",0,A61P|C07D|Y02A
11958815,2024-04-16,"N′-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)-2-naphthimidamide as antimicrobial compound",0,A61P|C07D
11958814,2024-04-16,"3-(4-nitrophenyl)-5-((2-isopropyl-5-methylphenoxy)methyl)-1,2,4-oxadiazole as an anti-cancer and antimicrobial compound",0,A61P|C07D|Y02A
11958811,2024-04-16,"1-[4,5-bis(4-bromophenyl)-1-hexyl-1H-imidazol-2-yl]-2-naphthol as an antimicrobial compound",0,A61P|C07D|Y02A
11957663,2024-04-16,"3-(2,4,5-tris(4-chlorophenyl)-1H-imidazol-1-yl) propanoic acid as an antimicrobial compound",0,A61K|A61P|C07D
11952385,2024-04-09,"12-bromo-2,16-dioxa-9,9,18,18-tetramethylpentacyclo[7.7.5.0 1, 21.0 3,8.0 10,15]henicosa3(8),10,12,14-tetraene-7,20-dione as an antimicrobial compound",0,A61P|C07D
11952383,2024-04-09,Aza-podophyllotoxin analogues as potential anti-cancer agents,0,A61P|C07D
11952382,2024-04-09,"2-benzo-[3,4-b]quinolino-[b,g]indeno[1,2:3,4]fluoreno-[1,2-d]oxonine-24-flouro-5,11,16,21-tetraone as an antimicrobial compound",0,A61P|C07D
11952378,2024-04-09,"Pyrrolo[2,3-c]isoquinoline-1,2-dione compounds as CK2 inhibitors",1,A61P|C07D
11952371,2024-04-09,"2-[(1,3-benzoxazol-2-yl)imino]-5,5-diphenylimidazolidin-4-one as an antimicrobial compound",0,A61P|C07D
11952361,2024-04-09,"2-(1-(3-(dimethylamino)propyl)-4,5-diphenyl-1H-imidazol-2-yl) pyridin-3-ol as an antitumor and antimicrobial compound",0,A61P|C07D
11952354,2024-04-09,"5-((2-isopropyl-5-methylphenoxy)methyl)-3-(naphthalen-2-yl)-1,2,4-oxadiazole as an anti-cancer and antimicrobial compound",0,A61P|C07D
11952348,2024-04-09,"4,5-bis(4-bromophenyl)-1-hexyl-2-(4-hydroxy-3-dimethoxyphenyl)-1H-imidazole as an antimicrobial compound",0,A61P|C07D
11952331,2024-04-09,Methods for making selective organoselenium-based ligands for the dispersive liquid-liquid microextraction of copper and zinc ions,0,C07C|G01N|Y10T
11952325,2024-04-09,"5,5′-naphthalene-1,5-diylbis(diazene-2,1-diyl)bis(2-hydroxybenzaldehyde) as an antioxidant compound",0,A61K|C07C
11946839,2024-04-02,Method of cleaning of adsorbed molecules in drying state on metal oxide by UV-visible assisted photocatalysis,0,B08B|G01N
11945823,2024-04-02,"Substituted pyrrolo[2,3-d]pyrimidines as CK2 inhibitors",0,A61P|C07D
11945821,2024-04-02,"5-substituted aminopyrazino[2′,1′:2,3]imidazo[4,5-C][2,7]naphthyridine compounds as CK2 inhibitors",0,A61P|C07D
11945820,2024-04-02,"Pyrrolo[3,2-c][2,6]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors",1,A61P|C07D
11945819,2024-04-02,"Dimethyl 7-bromo-1-(4-substituted benzoyl)pyrrolo[1,2-a]quinoline-2,3-dicarboxylates as anti-inflammatory agents",0,A61P|C07B|C07D
11945818,2024-04-02,"Pyrrolo[3,2-c]quinoline compounds as CK2 inhibitors",0,A61K|A61P|C07D
11945800,2024-04-02,"1-cyclopropyl-6-fluoro-4-oxo-7-(4-((5-oxo-2-phenyl-4-(quinolin-2-ylmethylene)-4,5-dihydro-1H-imidazol-1-yl)methyl)piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid as an anti-inflammatory and anticancer compound",0,A61P|C07D
11945793,2024-04-02,"9-(2-hydroxypyridin-3-yl)-10[3-(dimethylamino)propyl]-3,4,6,7,9,10-hexahydroacridine-1,8(2H,5H)-dione as an antimicrobial compound",0,A61P|C07D|Y02A
11945783,2024-04-02,"4-(4,5-bis(4-bromophenyl)-2-(4-methoxyphenyl)-1H-imidazol-1-yl)butanoic acid as an antimicrobial compound",0,A61P|C07D
11945768,2024-04-02,"8-(3-flurobenzylideneamino)naphthalene-1,3-disulfonic acid as an antioxidant compound",0,A61P|C07C
11945765,2024-04-02,"4,4′-naphthalene-1,5-diylbis(diazene-2,1-diyl)bis(2-methylphenol) as an antioxidant compound",0,A61P|C07C
11939354,2024-03-26,Fusion peptide inhibitors of human coronavirus 229E,1,A61P|C07K
11939330,2024-03-26,"Pyrido[3,4-b]indole-6-carboxylic acid compounds as CK2 inhibitors",0,A61P|C07D
11939326,2024-03-26,"7-(4-((5-(benzylideneamino)-2-thioxo-1,3,4-thiadiazol-3(2H)-yl)methyl)piperazin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid as an anti-inflammatory and anticancer compound",0,A61P|C07D
11939316,2024-03-26,"9-(6-flouro-2-hydroxyouinolin-3-yl)-10-(2-hydroxyethyl)-3,6-diphenyl-3,4,6,7,9,10-hexhydroacridine-1,8(2h,5h)-dione as an antimicrobial compound",0,A61P|C07D|Y02A
11939315,2024-03-26,"Ethyl 2-[9-(2-hydroxypyridin-3-yl)-3,6-diphenyl-1,8-dioxo-3,4,9,10-tetrahydroacridine-10-yl]-acetate as an antimicrobial compound",0,A61P|C07D
11939305,2024-03-26,"Ethyl 2-(5-(3-fluorophenyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)acetate as an antimicrobial compound",0,A61P|C07D|Y02A
11939304,2024-03-26,"Ethyl 6-(5-(3-fluorophenyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)hexanoate as an antimicrobial compound",0,A61P|C07D
11939299,2024-03-26,"4-((2-(2-(2-(4-methoxyphenyl)-4,5-diphenyl-1H-imidazol-1-yl)acetyl)hydrazono)methyl)benzoic acid as an anti-cancer compound",0,A61P|C07D
11939298,2024-03-26,"5-(4,5-bis(4-bromophenyl)-2-(4-chlorophenyl)-1H-imidazol-1-yl)pentanoic acid as an antimicrobial compound",0,A61P|C07D|Y02A
11939295,2024-03-26,6-(3-hydroxyphenyl)-2-methoxy-4-(3-methylphenyl)nicotinonitrile as an antimicrobial compound,0,A61P|C07D
11939294,2024-03-26,"1-(2-(substituted phenyl)-2-oxoethyl)-3,5-dimethylpyridin-1-ium bromides as antitubercular agents",0,A61P|C07D
11938151,2024-03-26,Method of making gold nanoparticles capped with Reseda arabica extract and treatment method using the same,1,A61K|A61P|B82Y
11938120,2024-03-26,"Ethyl 2-substituted-1-(substitutedbenzoyl)-7-methylpyrrolo[1,2-a]quinoline-3-carboxylate derivatives as anti-tubercular agents",0,A61K|A61P
11932687,2024-03-19,ELISA for diagnosis of Haemonchus longistipes infection in camels,0,C07K|G01N
11932656,2024-03-19,"Thieno[2,3-d]pyrimidines as COX-2 inhibitors",0,A61P|C07D
11932655,2024-03-19,"12-bromo-2,16-dioxapentacyclo[7.7.5.01,21.03,8.010,15]henicosa3(8),10,12,14-tetraene-7,20-dione as an antimicrobial compound",0,A61P|C07D|Y02A
11932651,2024-03-19,"2-benzo-[3,4-B]quinolino-[b,g]indeno[1′,2′:3,4]fluoreno-[1,2-d]oxonine-24-chloro-5,11,16,21-tetraone as an antimicrobial compound",0,A61P|C07D|Y02A
11932649,2024-03-19,"5-(3-substituted phenyl)-pyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,8H)-trione derivatives as anticancer agents",0,A61P|C07D
11932642,2024-03-19,"Substituted pyrido[3′,4′:4,5]pyrrolo[3,2-b][1,6]naphthyridines as CK2 inhibitors",0,A61P|C07D
11932641,2024-03-19,"Pyrido[4′,3′:4,5]pyrrolo[3,2-b][1,7]naphthyridine compounds as CK2 inhibitors",0,A61P|C07D
11932640,2024-03-19,"Pyrrolo[3,4-b]quinoline compounds as antibacterial agents",0,A61P|C07D|Y02A
11932632,2024-03-19,"N'-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)benzo[d][1,3]dioxole-5 carboximidamide as an antimicrobial compound",0,A61P|C07D|Y02A
11932622,2024-03-19,"2-(1-(2-hydroxypropyl)-4,5-diphenyl-1H-imidazol-2-yl)pyridine as an anticancer compound",0,A61P|C07D
11932621,2024-03-19,"2-[9-(2-hydroxypyridin-3-yl)-1,8-dioxo-1,2,3,4,5-6,7,8,9,10-decahydroacridin-10-yl]-acetate as an antimicrobial compound",0,A61P|C07B|C07D|Y02A
11932620,2024-03-19,"Ethyl 2-[9-(6-flouro-2-hydroxyquinolin-3-yl)-1,8-dioxo-3,4,9,10-tetrahydroacridine-10-yl]-acetate as an antimicrobial compound",0,A61P|C07D|Y02A
11932619,2024-03-19,"3-(2-(6-Methoxypyridin-3-yl)-4,5-diphenyl-1H-imidazol-1-yl)-N,N-dimethylpropan-1-amine as an anticancer compound",0,A61P|C07B|C07D
11932612,2024-03-19,"6-(5-(3-fluorophenyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)hexanoic acid as an antimicrobial compound",0,A61P|C07D
11932611,2024-03-19,"3-(5-(3-fluorophenyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)propanoic acid as an antimicrobial compound",0,A61P|C07D|Y02A
11932610,2024-03-19,"4-(5-(3-fluorophenyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)butanoic acid as an antimicrobial compound",0,A61P|C07D|Y02A
11932609,2024-03-19,"Substituted 1,4-dihydropyrimidines as antitubercular agents",0,A61P|C07D
11932608,2024-03-19,"4-((2-(2-(2-(4-hydroxyphenyl)-4,5-diphenyl-1H-imidazol-1-yl)acetyl)hydrazono)methyl)benzoic acid as an anticancer compound",0,A61P|C07D
11932607,2024-03-19,"4-(2,4,5-tris(4-chlorophenyl)-1H-imidazol-1-yl)benzoic acid as an antimicrobial compound",0,A61P|C07D|Y02A
11932605,2024-03-19,"9-(4-nitrobenzylidene)-4-(4-nitrophenyl)-3-cyano-2-methoxy-6,7,8,9-tetrahydro-5h-cyclohepta[b]pyridine as an antimicrobial compound",0,A61P|C07D|Y02A
11932604,2024-03-19,"9-(2-hydroxyphenyl)-10-[3-(dimethylamino)propyl]- 3,4,6,7,9,10-hexahydroacridine-1,8(2H,5H)-dione as an antimicrobial compound",0,A61P|C07B|C07D|Y02A
11932594,2024-03-19,"8-((2-hydroxy-5-methylphenyl)diazenyl)naphthalene-1,3-disulfonic acid as an antioxidant compound",0,A61P|C07C
11930824,2024-03-19,Marine algae for insect biocontrol,0,A01N|A01P|C05F|C12N|C12P
11926629,2024-03-12,"Pyrido[3′,4′:4,5]pyrrolo[2,3-c]isoquinoline compounds as CK2 inhibitors",1,A61P|C07D
11926627,2024-03-12,Substituted 7-methyl quinoline derivatives as antitubercular agents,0,A61P|C07D
11926621,2024-03-12,"N′-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)benzo[d][1,3]dioxole-5-carboximidamide as an antimicrobial compound",0,A61P|C07D|Y02A
11926620,2024-03-12,"1-Cyclopropyl-6-fluoro-4-oxo-7-(4-((2-thioxobenzo[d]oxazol-3(2H)-yl)methyl)piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid as an antimicrobial and anticancer compound",0,A61P|C07D
11926615,2024-03-12,"2-alkoxy[4,3:6,4-terpyridine]-3-carbonitriles as antimicrobial compounds",0,A61P|C07D
11926611,2024-03-12,"2-(2-ethoxyethoxy)-6-phenyl-4,4′-bipyridine-3-carbonitrile as an antimicrobial compound",1,A61P|C07D|Y02A
11926610,2024-03-12,"9-(2-hydroxypyridin-3-yl)10-(2-hydroxyethyl)-3,6-diphenyl-3,4,6,7,9,10-hexahydroacridine1,8(2H,5H)-dione as an antimicrobial compound",0,A61P|C07D
11926609,2024-03-12,"6′-(3-chlorophenyl)-2′-ethoxy-3,4′-bipyridine-3′-carbonitrile as antimicrobial compounds",0,A61P|C07D|Y02A
11926602,2024-03-12,"4-amino-5-(4-fluoro-3-phenoxyphenyl)-4H-1,2,4-triazole-3-thiol derivatives as antifungal agents",0,A61K|A61P|C07D
11926601,2024-03-12,"5-spiro 9,10-dihydroanthracene derivative of imidazolidine-2,4-dione as an anticancer agent",0,A61P|C07D
11926599,2024-03-12,"1-(2-chlorobenzylideneamino)-5,5-diphenylimidazolidine-2,4-dione as an antimicrobial compound",0,A61P|C07D
11926598,2024-03-12,"1-(4-nitrobenzylideneamino)-5-phenylimidazolidine-2,4-dione as an antimicrobial compound",0,A61P|C07D|Y02A
11926597,2024-03-12,"4,5-bis(4-chlorophenyl)-1-hexyl-2-(3,4-dimethoxyphenyl)-1H-imidazole as an antimicrobial compound",0,A61P|C07D
11926595,2024-03-12,2-(2-ethoxyethoxy)-6-(4-hydroxyphenyl)-4-(4-methylphenyl)nicotinonitrile as an antimicrobial compound,1,A61P|C07D
11926594,2024-03-12,"6′-(3-bromophenyl)-2′-ethoxy-3,4′-bipyridine-3′-carbonitrile as an antioxidant compound",0,A61P|C07D
11926579,2024-03-12,"8-(4-methoxybenzylideneamino)naphthalene-1,3-disulfonic acid as an antioxidant compound",0,A61P|C07C
11926578,2024-03-12,"8-(4-nitroxybenzylideneamino)naphthalene-1,3-disulfonic acid as an antioxidant compound",0,A61P|C07C
11926576,2024-03-12,"4,4′-naphthalene-1,5-diylbis(diazene-2,1-diyl)dibenzene-1,2-diol as an antioxidant compound",0,A61P|C07C
11925630,2024-03-12,"6′-(2-bromophenyl)-2′-methoxy-3,4′-bipyridine-3′-carbonitrile as an antioxidant compound",0,A61K|A61P
11919900,2024-03-05,"1-substituted benzoyl-4-bromopyrrolo[1,2-a]quinoline-3-carboxylate derivatives as antitubercular agents",0,A61P|C07D
11919893,2024-03-05,"7-(4-((5-(2-bromobenzylideneamino)-2-thioxo-1,3,4-thiadiazol-3(2H)-yl)methyl) piperazin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid as an anti-inflammatory compound",0,A61P|C07D
11919892,2024-03-05,"2-(benzo[d]thiazol-2-yl)-N'-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)acetimidamide as an antimicrobial compound",0,A61P|C07D|Y02A
11919885,2024-03-05,4-(4-bromophenyl)-2-alkyloxy-6-(2-oxo-2H-1-benzopyran-3-yl)pyridine-3-carbonitrile as antimicrobial compounds,0,A61P|C07D
11919878,2024-03-05,"9-(2-hydroxypyridin-3-yl)-10-(2-phenylethyl)-3,3,6,6-tetramethyl-3,4,6,7,9,10-hexahydroacridine1,8(2H,5H)-dione as an antimicrobial compound",1,A61P|C07D
11919873,2024-03-05,"1,3-benzothiazol-2-yl-N′-(benzoyloxy)ethanimidamide as an antitumor and antimicrobial compound",3,A61P|C07D|Y02A
11919872,2024-03-05,"N′-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)benzimidamide as an antimicrobial compound",0,A61P|C07B|C07D|Y02A
11919871,2024-03-05,"3-(3-chlorophenyl)-5-((2-isopropyl-5- methylphenoxy)methyl)-1,2,4-oxadiazole as an anti-cancer and antimicrobial compound",0,A61P|C07D|Y02A
11919867,2024-03-05,"5-(4,5-bis(4-bromophenyl)-2-(4-methoxyphenyl)-1H-imidazol-1-yl)pentanoic acid as an antimicrobial compound",1,A61P|C07D|Y02A
11919862,2024-03-05,"6′-(4-bromophenyl)-2′-ethoxy-3,4′-bipyridine-3′-carbonitrile as an antioxidant",0,A61P|C07D
11919861,2024-03-05,"6′-(2-bromophenyl)-2′-ethoxy-3,4′-bipyridine-3′-carbonitrile as an antioxidant compound",0,A61P|C07D
11919860,2024-03-05,1-2(-(substituted phenyl)-2-oxoethyl)-4-(isopropoxycarbonyl)pyridin-1-ium bromides as anti-tubercular agents,0,A61P|C07D
11919843,2024-03-05,Selective organoselenium-based ligands for the dispersive liquid-liquid microextraction of copper and zinc ions from real samples,0,C07C|G01N|Y10T
11919837,2024-03-05,"4,4′-naphthalene-1,5-diylbis(diazene-2,1-diyl)dinaphthalen-1-ol as an antioxidant compound",0,A61P|C07C
11919043,2024-03-05,Intelligent sorting for date palm fruit,0,B07C|G01N
11912698,2024-02-27,"1-cyclopropyl-6-fluoro-7-(4-((5-(4-methoxybenzylideneamino)-2-thioxo-1,3,4-thiadiazol-3(2H)-yl)methyl)piperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid as an anti-inflammatory and anticancer compound",0,A61P|C07D
11912697,2024-02-27,"1,3-benzothiazol-2-yl-N′-[(pyridine-3-carbonyl)oxy]ethanimidamide as an antitumor and antimicrobial compound",3,A61P|C07D|Y02A
11912694,2024-02-27,"2-(benzo[d]oxazol-2-yl)-N′-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)acetimidamide as an antimicrobial compound",0,A61P|C07D|Y02A
11912683,2024-02-27,"(6-methyl-4-substitutedphenyl-2-oxo/thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)(piperidin-1-yl)methanones as antitubercular agents",0,A61P|C07D
11912677,2024-02-27,"1,3-benzothiazol-2-yl-N'-[(3-phenylprop-2-enoyl)oxy]ethanimidamide as an anticancer and antimicrobial compound",0,A61P|C07D
11912676,2024-02-27,"N'-[(4-chlorobenzoyl)oxy]-1,3-benzothiazole-2-carboximidamide as an antitumor and antimicrobial compound",0,A61P|C07D
11912675,2024-02-27,"N'-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)-3,4-dimethoxybenzimidamide as an antimicrobial compound",0,A61P|C07B|C07D|Y02A
11912671,2024-02-27,"Ethyl 3-(5-(3-fluorophenyl)-4-phenyl-4H-1,2,4- triazol-3-ylthio)propanoate as an antimicrobial compound",0,A61P|C07D|Y02A
11912670,2024-02-27,"Ethyl 4-(5-(3-fluorophenyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)butanoate as an antimicrobial compound",0,A61P|C07D|Y02A
11912665,2024-02-27,"4-(2,4,5-tris(4-chlorophenyl)-1H-imidazol-1-yl)butanoic acid as an antimicrobial compound",0,A61P|C07D|Y02A
11912662,2024-02-27,"2-alkoxy[4,3:6,2-terpyridine]-3-carbonitrile as antimicrobial compounds",0,A61P|C07D
11912652,2024-02-27,"8-(2-hydroxybenzylideneamino)naphthalene-1,3-disulfonic acid as an antioxidant compound",0,A61K|A61P|C07C
11905290,2024-02-20,"5-substituted aminopyrimido[6′,1′:2,3]imidazo[4,5-c][1,6]naphthyridine compounds as CK2 inhibitors",0,A61P|C07D
11905289,2024-02-20,"Pyrido[3′,4′:4,5]pyrrolo[3,2-C]naphthyridine compounds as CK2 inhibitors",2,A61P|C07D
11905288,2024-02-20,"Pyrido[3″,4″:4′, 5′]pyrrolo[3′,2′:4,5]imidazole[1,2-c]pyrimidine compounds as CK2 inhibitors",0,A61P|C07D
11905282,2024-02-20,"1-cyclopropyl-7-(4-((5-(2,4-dichlorobenzylideneamino)-2-thioxo-1,3,4-thiadiazol-3(2H)-yl)methyl)piperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid as an anti-inflammatory compound",0,A61P|C07D
11905280,2024-02-20,2-(benzo[d]oxazol-2-yl)-N'-(picolinoyloxy)acetimidamide as an antimicrobial compound,4,A61P|C07B|C07D|Y02A
11905278,2024-02-20,6-(6-bromo-2-oxo-2H-chromen-3-yl)-4-(2-chlorophenyl)-2-alkoxynicotinonitrile as an antimicrobial compound,0,A61P|C07D|Y02A
11905277,2024-02-20,2-alkyloxy-6-(2-oxo-2H-1-benzopyran-3-yl)-4-phenylpyridine-3-carbonitrile as an antimicrobial compound,0,A61P|C07D|Y02A
11905272,2024-02-20,"3-(2-(4-methoxypyridin-3-yl)-4,5-diphenyl-1H-imidazol-1-yl)-N,N-dimethylpropan-1-amine as an anti-cancer compound",0,A61P|C07B|C07D
11905265,2024-02-20,"3,4-dimethoxy-n′-(2-(5-phenyl-1,3,4-oxadiazol-2ylthio)acetoxy)benzimidamide as an antimicrobial compound",0,A61K|A61P|C07D
11905264,2024-02-20,"N′-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)-4-nitrobenzimidamide as an antimicrobial compound",0,A61P|C07B|C07D
11905263,2024-02-20,"4-nitro-N′-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)benzimidamide as an antimicrobial compound",0,A61P|C07B|C07D
11905262,2024-02-20,"N′-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)-2-naphthimidamide as an antimicrobial compound",1,A61P|C07D|Y02A
11905261,2024-02-20,"3-(4-methoxyphenyl)-5-{[5-methyl-2-(propan-2-yl)phenoxy]methyl}-1,2,4-oxadiazole as an antitumor and antimicrobial compound",0,A61P|C07B|C07D
11905260,2024-02-20,N′-(1-naphthoyloxy)-2-(benzo[d]oxazol-2-yl)acetimidamide as an antimicrobial compound,0,A61P|C07D
11905259,2024-02-20,2-(benzo[d]oxazol-2-yl)-N′-(4-(dimethylamino)benzoyloxy)acetimidamide as an antimicrobial compound,0,A61P|C07B|C07D|Y02A
11905254,2024-02-20,"1-(3-chlorobenzylideneamino)-5,5-diphenylimidazolidine-2,4-dione as an antimicrobial compound",0,A61P|C07D
11903944,2024-02-20,Experimental model using pazopanib-induced cardiotoxicity,0,A61K
11903390,2024-02-20,Enhanced Curcuma longa productivity and medicinal values by using Moringa oleifera leaf extract,0,A01N|A01P|A61K
11897947,2024-02-13,ELISA for diagnosis of Haemonchus longistipes infection in camels,0,C07K|G01N
11897902,2024-02-13,Nano-sized mixed ligand [4-bromo-2-(quinolin-2-yliminomethyl)-phenol imine- phenanthroline] Ru(III) complex for medicinal applications,1,A61K|A61P|B82Y|C07F
11897901,2024-02-13,"6-amino-8,9-di(4-methoxyphenyl)-2-oxo-3,9-dihydro-2H-[1,3]thiazolo[5′,4′:5,6]pyrano[2,3-b]pyridine-7-carbonitrile as anticancer compound",0,A61P|C07D
11897883,2024-02-13,"Pyrrolo[3,2-c][1,6]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors",3,A61P|C07D
11897881,2024-02-13,"Substituted pyrido[3,4-b]indole-3-carboxylic acids as CK2 inhibitors",0,A61P|C07D
11897859,2024-02-13,Coumarin compounds as antibacterial agents,0,A61P|C07D
11897855,2024-02-13,Antioxidant vitamin C derivative,0,A61K|A61P|A61Q|C07D
11897850,2024-02-13,"N′-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)-4-methoxybenzimidamide as an antimicrobial compound",0,A61P|C07D
11897849,2024-02-13,"N′-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)-1-naphthimidamide as antimicrobial compound",1,A61P|C07D
11896638,2024-02-13,Topical skin cream,0,A61K
11891397,2024-02-06,"Pyrido[4′,3′:4,5]pyrrolo[3,2-c][1,7]naphthyridin-10-one compounds as CK2 inhibitors",1,A61P|C07D
11891396,2024-02-06,"5-substituted pyrido[3″,4″:4′,5′]pyrrolo[3′,2′:4,5]imidazo[1,2-a]pyrazine compounds as CK2 inhibitors",0,A61P|C07D
11891395,2024-02-06,"5-substituted aminopyrazino[2′,1′:2,3]imidazo[4,5-C][2,7]naphthyridine compounds as CK2 inhibitors",0,A61P|C07D
11891394,2024-02-06,"Pyrrolo[2,3-c][1,6]naphthyridine-8-carboxylic acid compounds as CK2 inhibitors",1,A61P|C07D
11891390,2024-02-06,"3-substituted amino-2-arylpyrrolo[2,3-c]pyridines as CK2 inhibitors",0,A61P|C07D
11891385,2024-02-06,"1-cyclopropyl-7-(4-((5-(3,5-dichlorobenzylideneamino)-2-thioxo-1,3,4-thiadiazol-3(2H)-yl)methyl)piperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic aci d as an anti-inflammatory compound",0,A61P|C07D
11891377,2024-02-06,"Pyrrolo[3,2-c][2,7]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors",1,A61P|C07D
11891366,2024-02-06,"4-methoxy-n′-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)benzimidamide as an antimicrobial compound",0,A61P|C07D|Y02A
11891362,2024-02-06,"N2,N4-disubstituted pyrimidine-2,4-diamine compounds as antibacterial agents",0,A61P|C07D
11890367,2024-02-06,Anti-aging composition based on mixed ester of stilbenic extract,0,A61K|A61Q
11884677,2024-01-30,"5-(substitutedphenyl)-7-imino-7,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as anti-inflammatory agents",0,A61P|C07D
11884670,2024-01-30,"Pyrido[4′,3′:4,5]pyrrolo[3,2-c][2,7]naphthyridin-10-one compounds as CK2 inhibitors",1,A61P|C07D
11884669,2024-01-30,"Pyrrolo[3,2-c][1,7]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors",1,A61K|A61P|C07D
11884668,2024-01-30,"Substituted pyrido[3′,4′:4,5]pyrrolo[2,3-c]quinolines as CK2 inhibitors",1,A61P|C07D
11884667,2024-01-30,"Substituted pyrrolo[2,3-c][2,7]naphthyridines as CK2 inhibitors",2,A61P|C07D
11884658,2024-01-30,"1-cyclopropyl-6-fluoro-4-oxo-7-(4-((2-thioxobenzo[d]thiazol-3(2H)-yl)methyl)piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid as an antimicrobial compound",0,A61P|C07D
11884651,2024-01-30,"7-(4-((4-benzylidene-5-oxo-2-phenyl-4,5-dihydro-1H-imidazol-1-yl)methyl)piperazin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid as an anti-inflammatory compound",0,A61P|C07D
11884637,2024-01-30,"3-(4-chlorophenyl)-5-{[5-methyl-2-(propan-2-yl)phenoxy]methyl}-1,2,4-oxadiazole as an antitumor and antimicrobial compound",1,A61P|C07D
11884631,2024-01-30,Substituted phenyl quinolin-l-ium bromide derivative as anti-tubercular agents,0,A61P|C07D
11883450,2024-01-30,Extract of Agathis robusta as antifungal agent,0,A61K|A61P
11883442,2024-01-30,Composition for treating irritable bowel syndrome,0,A61K|A61P
11883379,2024-01-30,"9-flouro-dibenzo[B,G]indeno[1′, 2′:3,4]fluoreno-[1,2-D]oxonine-5, 11, 16,21-tetraone as an antimicrobial agent",0,A61K|A61P|C07D|Y02A
11879835,2024-01-23,Device for detecting toxic elements in plastic products and determining potential health risks,0,G01N|G08B
11878978,2024-01-23,"Pyrrolo[2,3-c]quinoline compounds as CK2 inhibitors",0,A61P|C07D
11878960,2024-01-23,"Antioxidant therapeutic potential of N,N′-diphenyl-1,4-phenylenediamine and a novel selenide on minimizing breast cancer hazards",0,A61K|C07D
11878043,2024-01-23,Method for synthesizing silver nanoparticles from Amaranthus hybridus,0,A61K|A61P|B82Y
11878039,2024-01-23,Composition for treating Irritable Bowel Syndrome,0,A61K|A61P
11873306,2024-01-16,"Nano-sized 5,10,15,20-tetrakis (4-hydroxyphenyl)-porphyrins pd(II) complex for super medicinal applications",0,A61K|A61P|B82Y|C07D|Y02A
11873299,2024-01-16,"7-(4-((5-(4-chlorobenzylideneamino)-2-thioxo-1,3,4-thiadiazol-3(2H)-yl)methyl)iperazin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid as an anti-inflammatory compound",1,A61P|C07B|C07D
11866755,2024-01-09,Ferrous pebbles as a catalyst for enhanced methane generation from rice husk,0,C12M|C12P|Y02E
11866461,2024-01-09,Fusion peptide inhibitors of human coronavirus 229E,0,A61P|C07K
11866437,2024-01-09,"1,2-dioxo-2,3-dihydro-1H-pyrrolo[2,3-c]quinoline-7-carboxylic acid compounds as CK2 inhibitors",1,A61P|C07D
11866349,2024-01-09,Method of chromium (CR+6) removal from wastewater using copper augmented biochar,0,A61K|B01J|C02F
11865153,2024-01-09,Topical skin cream,0,A61K
11858935,2024-01-02,"Pyrrolo[2,3-c][1,7]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors",1,A61P|C07D
11858934,2024-01-02,"Substituted pyrido[4′,3′:5,6]pyrimido[1,2-a]indoles as CK2 inhibitors",0,A61P|C07D
11858893,2024-01-02,Aza-Podophyllotoxin analogues as potential anti-cancer agents,0,A61P|C07D
11851430,2023-12-26,"Pyrido[4,3-B]indole-7-carboxylic acid compounds as CK2 inhibitors",0,A61P|C07D
11851413,2023-12-26,"1,3-benzothiazol-2-yl-N'-[(naphthalene-1-carbonyl)oxy]ethanimidamide as an antitumor and antimicrobial compound",0,A61P|C07D
11850271,2023-12-26,Topical skin cream,0,A61K
11845971,2023-12-19,Generation of methane from digestion of marine brown algae,0,C12N|C12P|C12R|Y02E
11845750,2023-12-19,Antiproliferative selenated-folate hybrids,1,C07D|C12N|C12Y
11845749,2023-12-19,"Substituted pyrido[4′,3′:5,6]pyrazino[1,2-a]indoles as anticancer agents",0,A61P|C07D
11845746,2023-12-19,"Ethyl 2-substituted-1-(substitutedbenzoyl)-7-methylpyrrolo[1,2-a]quinoline-3-carboxylate derivatives as anti-tubercular agents",0,A61P|C07D
11845743,2023-12-19,Pyrazolidinedione derivatives and their use as PPAR-gamma inhibitors,0,A61P|C07D
11844781,2023-12-19,Polymeric clotrimazole biofilm for the treatment of otomycosis,0,A61K|A61P
11840547,2023-12-12,Nano-sized 4-Bromo-2-[(9H-purin-6-ylimino)-methyl]-phenol imine Pd(II) complex for superior pharmaceutical applications,0,A61P|C07F|Y02A
11833246,2023-12-05,Rectal gel with date palm phenolics and vanillic acid,0,A61K|A61P
11833230,2023-12-05,Root canal irrigant from Rosa damascena mill,0,A61C|A61K|A61Q
11833181,2023-12-05,Method of treating or preventing Alzheimer's Disease,0,A61K
11833134,2023-12-05,Polymeric clotrimazole biofilm for the treatment of otomycosis,0,A61K|A61P
11833132,2023-12-05,Method of synthesis of a nanocomposite including silymarin-loaded collagen nanoparticles,0,A61K|A61P
11826418,2023-11-28,Virus-like particle (VLP)-based vaccine against CVB4,0,A61K|A61P|C12N
11820974,2023-11-21,Pomegranate molasses medium for culturing microbes,0,C12N
11820779,2023-11-21,Aza-podophyllotoxin analogues as potential anti-cancer agents,0,A61P|C07D
11815351,2023-11-14,Device for monitoring internal pipe deposit accumulation,0,G01B|G01N
11813288,2023-11-14,Covid-19 binding aerosols,0,A01N|A01P|A61K
11813287,2023-11-14,Covid-19 binding aerosols,1,A01N|A01P|A61K
11812751,2023-11-14,Biocontrol agents for use against soil and air-borne fungal pathogens,0,A01N|C12N|C12R
11807640,2023-11-07,"7-isopropyl 1-ethyl/methyl 3-(substituted benzoyl)-2-substituted indolizine-1,7-dicarboxylates as anti-tubercular agents",2,A61P|C07D
11807639,2023-11-07,"Pyrrolo[3,4-b]quinoline compounds as antibacterial agents",0,A61P|C07D|Y02A
11807607,2023-11-07,Aminocarbazole compounds as antibacterial agents,0,A61P|C07D
11806430,2023-11-07,Rectal gel with date palm phenolics and vanillic acid,0,A61K|A61P
11806378,2023-11-07,Therapeutic composition including phenolic compounds derived from Opuntia littoralis,0,A61K
11806363,2023-11-07,Green synthesis of silver nanoparticles using euphorbia dendroides aqueous extract,0,A61K|A61P
11806358,2023-11-07,Method of treating trypanosomiasis,0,A61K|A61P
11805773,2023-11-07,Nanocomposite including water-soluble nano-polymer and mesoporous silica nanoparticles encapsulated with azole derivatives,0,A01N|A01P|A61K|C01B|C07D
11802130,2023-10-31,"Benzofuro[3,2-c]chromen-6-one compounds as antibacterial agents",2,A61K|A61P|C07D|Y02A
11802129,2023-10-31,"Pyrido[3,4-b]indol-1-one compounds as anticancer agents",0,A61P|C07D
11801249,2023-10-31,Broad-spectrum antitrypanosomal compounds,0,A61K|Y02A
11801247,2023-10-31,Method of treating trypanosomiasis,0,A61K|A61P
11788998,2023-10-17,Ethylene sensor and method of making same,0,B23K|C23C|G01N|G01R
11786535,2023-10-17,Methods of inhibiting cyclooxygenase,0,A61K
11780838,2023-10-10,"Pyrrolo[3,2-b]quinoline compounds as antibacterial agents",0,A61P|C07D
11780809,2023-10-10,Carbazole compounds as antibacterial agents,0,A61P|C07D
11773137,2023-10-03,Arid5a peptide inhibitors,0,A61K|A61P|C07K|G01N
11773093,2023-10-03,"N-(pyrimido[2,3-b]indol-7-yl)acetamide compounds as antibacterial agents",0,A61P|C07D
11773092,2023-10-03,"Pyrido[3,4-b]indol-1-one compounds as antibacterial agents",0,A61P|C07D
11773084,2023-10-03,4-arylamino-2-(6-indolylamino)pyrimidine compounds as antibacterial agents,0,A61P|C07D
11767360,2023-09-26,Elisa for diagnosis of Haemonchus longistipes infection in camels,0,C07K|G01N
11761885,2023-09-19,Device for determining fish gender,0,A61B|G01N
11731980,2023-08-22,"Furo[3,4-b]quinolone compounds as antibacterial agents",1,A61P|C07D|Y02A
11731970,2023-08-22,"Pyrrolo[2,3-b]quinoline compounds as antibacterial agents",0,A61P|C07D
11731942,2023-08-22,3-substituted quinolin-2-one compounds as antibacterial agents,0,A61P|C07D
11731939,2023-08-22,Indole-based chalcone compounds as antibacterial agents,0,A61P|C07D
11730759,2023-08-22,Sulfasalazine-loaded zinc oxide nanoparticles for the treatment of ulcerative colitis,0,A61K|A61P
11707504,2023-07-25,Fusion peptide inhibitors of human coronavirus 229E,1,A61K|A61P
11654138,2023-05-23,Therapeutic agents for treating and preventing autoimmune diseases and cancer and a screening method,0,A61K|G01N
11602519,2023-03-14,Method for preventing myocardial infarction using eucalyptol,0,A61K|A61P
11536664,2022-12-27,Method for detecting a biomolecule by surface-enhanced Raman spectroscopy,0,G01N
11530217,2022-12-20,Antitubercular compounds,2,A61P|C07D
11479582,2022-10-25,Anti-SARS-CoV-2 fusion peptides,3,A61K|C07K|C12N|G01N
11478464,2022-10-25,Method for treating inflammation,1,A61K|A61P
11446286,2022-09-20,Treatment of fungal infections using dabigatran etexilate,0,A61K|A61P
11001608,2021-05-11,Arid5a peptide inhibitors,0,A61K|A61P|C07K|G01N
10975126,2021-04-13,MERS-CoV inhibitor peptides,4,A61K|C07K|C12N
